🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 422910109
- Market Cap
- Micro Cap · $60 Million
- Previous Symbol
- HBPC (changed 4/1/2013)
Business: Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on their proprietary technologies. Helix’s product development initiatives include their novel L-DOS47 new drug product candidate for the treatment of inoperable, locally advanced, recurrent or metastatic non-small cell lung cancer and Topical Interferon Alpha-2b for the treatment of potentially precancerous, low-grade cervical lesions caused by human papillomavirus (HPV) infections.
Company Contact
- CEO
- Donald H. Segal
- CFO
- Frank Michalargias
- Headquarters
- 305 Industrial Parkway South, Unit 3, Aurora, ONT L4G 6X7, Canada
- Phone
- 905-841-2300
- Fax
- 905-841-2244
- Investor Relations
- 905-841-2300 · ir@helixbiopharma.com